Extrauterine growth restriction in very preterm infant: etiology, diagnosis, and 2-year follow-up

Josep Figueras-Aloy1, Clara Palet-Trujols2, Isabel Matas-Barceló2

  • 1Neonatology Service, Institut Clínic de Ginecologia, Obstetricia i Neonatologia, BCNatal (Centre de Medicina Maternofetal i Neonatologia de Barcelona), Hospital Clínic, IDIBAPS (Institut d'Investigacions Biomèdiques August Pi I Sunyer), Universitat de Barcelona, Barcelona, Catalonia, Spain. jfiguer@clinic.cat.

Insights

Extrauterine growth restriction (EUGR) affects 15% of very preterm infants by age 2.5 years. This "true-EUGR" in non-small-for-gestational-age infants is linked to factors like low birth weight and male sex.

Area of Science:

  • Neonatology
  • Pediatric Growth and Development
  • Perinatal Medicine

Background:

  • Extrauterine growth restriction (EUGR) is commonly assessed in preterm infants, but its definition and impact, particularly in small-for-gestational-age (SGA) infants, require clarification.
  • Current growth monitoring relies on various charts, potentially leading to inconsistent EUGR diagnosis and management strategies.

Purpose of the Study:

  • To differentiate true EUGR in non-SGA infants from the postnatal growth patterns of SGA infants.
  • To identify fetal, maternal, and neonatal factors associated with EUGR in both SGA and non-SGA very-preterm infants.

Main Methods:

  • A cohort of 479 very-preterm infants (<32 weeks) was studied using INTERGROWTH-21st and WHO growth standards.
  • EUGR was defined as weight <10th percentile at 36-34 weeks postmenstrual age; catch-up growth and anthropometric deficits were assessed at 2-2.5 years.
  • Logistic regression analyzed risk factors associated with EUGR, stratified by SGA status at birth.

Main Results:

  • Overall EUGR was observed in 51% at discharge and 21% at 2-2.5 years.
  • In non-SGA infants, "true-EUGR" rates were 43% at discharge and 15% at 2-2.5 years.
  • Factors associated with "true-EUGR" included low birth weight, hyaline membrane disease, bronchopulmonary dysplasia, and male sex.

Conclusions:

  • A significant proportion (15%) of very-preterm infants experience "true-EUGR" by 2-2.5 years of age.
  • SGA infants show a postnatal evolution of fetal growth restriction rather than true EUGR, with head circumference normalizing over time.
  • Preeclampsia, low gestational age, severe neonatal morbidity, and male sex are independent risk factors for "true-EUGR" in non-SGA infants.